SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-Aveo Oncology Posts Q1 Loss Per Share Of $0.81

05/10/2021 18:17
BRIEF-Aveo Oncology Posts Q1 Loss Per Share Of $0.81

- Aveo Pharmaceuticals Inc AVEO.O:

  • AVEO ONCOLOGY REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

  • Q1 LOSS PER SHARE $0.81

  • Q1 REVENUE $1.9 MILLION

  • Q1 REVENUE ESTIMATE $1 MILLION -- REFINITIV IBES DATA

  • Q1 EARNINGS PER SHARE ESTIMATE $-0.55 -- REFINITIV IBES DATA

  • AVEO ONCOLOGY - BELIEVE CASH, EQUIVALENTS, WITH PRODUCT REVENUE FROM FOTIVDA LAUNCH, WOULD ENABLE MAINTANING OPERATIONS FOR AT LEAST 12 MONTHS FROM 10Q FILING

  • AVEO ONCOLOGY - EXPECTS COMMERCIAL SPEND WILL BE APPROXIMATELY $40 MILLION FOR YEAR

Source text for Eikon: ID:nBw2f2C5Fa

Further company coverage: AVEO.O


(([email protected];))